Sports Physical Therapy — Nutrition and Agility Training Effect on Performance in Tennis Players
Citation(s)
Abrams GD, Renstrom PA, Safran MR Epidemiology of musculoskeletal injury in the tennis player. Br J Sports Med. 2012 Jun;46(7):492-8. doi: 10.1136/bjsports-2012-091164. Epub 2012 May 25. Review.
Amiri-Khorasani M, Sahebozamani M, Tabrizi KG, Yusof AB Acute effect of different stretching methods on Illinois agility test in soccer players. J Strength Cond Res. 2010 Oct;24(10):2698-704. doi: 10.1519/JSC.0b013e3181bf049c.
Bangsbo J Performance in sports--With specific emphasis on the effect of intensified training. Scand J Med Sci Sports. 2015 Dec;25 Suppl 4:88-99. doi: 10.1111/sms.12605. Review.
Gomes RV, Moreira A, Coutts AJ, Capitani CD, Aoki MS Effect of carbohydrate supplementation on the physiological and perceptual responses to prolonged tennis match play. J Strength Cond Res. 2014 Mar;28(3):735-41. doi: 10.1519/JSC.0b013e3182a1f757.
Jeffreys I A task-based approach to developing context-specific agility. Strength & Conditioning Journal. 2011;33(4):52-9.
Jovanovic M, Sporis G, Omrcen D, Fiorentini F Effects of speed, agility, quickness training method on power performance in elite soccer players. J Strength Cond Res. 2011 May;25(5):1285-92. doi: 10.1519/JSC.0b013e3181d67c65.
Markovic G, Jukic I, Milanovic D, Metikos D Effects of sprint and plyometric training on muscle function and athletic performance. J Strength Cond Res. 2007 May;21(2):543-9.
Effects of Carbohydrate Loading With Agility Training on Performance in Tennis Players
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.